Related references
Note: Only part of the references are listed.Dicer Knockdown Inhibits Endothelial Cell Tumor Growth via MicroRNA 21a-3p Targeting of Nox-4
Gayle M. Gordillo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy
Claudia Bang et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Both mature miR-17-5p and passenger strand miR-17-3p target TIMP3 and induce prostate tumor growth and invasion
Xiangling Yang et al.
NUCLEIC ACIDS RESEARCH (2013)
MicroRNA-21-3p, a Berberine-Induced miRNA, Directly Down-Regulates Human Methionine Adenosyltransferases 2A and 2B and Inhibits Hepatoma Cell Growth
Ting-Fang Lo et al.
PLOS ONE (2013)
MicroRNAs in control of cardiac hypertrophy
Paula A. Da Costa Martins et al.
CARDIOVASCULAR RESEARCH (2012)
Long-term, efficient inhibition of microRNRNA function in mice using rAAV vectors
Jun Xie et al.
NATURE METHODS (2012)
Roles and Targets of Class I and IIa Histone Deacetylases in Cardiac Hypertrophy
Hae Jin Kee et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
miR-155 and its star-form partner miR-155* cooperatively regulate type I interferon production by human plasmacytoid dendritic cells
Haibo Zhou et al.
BLOOD (2010)
miR-21: a miRaculous Socratic paradox
Paula A. da Costa Martins et al.
CARDIOVASCULAR RESEARCH (2010)
A Novel Loss-of-Function DDAH1 Promoter Polymorphism Is Associated With Increased Susceptibility to Thrombosis Stroke and Coronary Heart Disease
Hu Ding et al.
CIRCULATION RESEARCH (2010)
Effects of Heart Rate and Anesthetic Timing on High-Resolution Echocardiographic Assessment Under Isoflurane Anesthesia in Mice
Jian Wu et al.
JOURNAL OF ULTRASOUND IN MEDICINE (2010)
MicroRNA-21 in Cardiovascular Disease
Yunhui Cheng et al.
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2010)
MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue
Sashwati Roy et al.
CARDIOVASCULAR RESEARCH (2009)
Long-Term Cardiac-Targeted RNA Interference for the Treatment of Heart Failure Restores Cardiac Function and Reduces Pathological Hypertrophy
Lennart Suckau et al.
CIRCULATION (2009)
Targeting histone deacetylases for heart failure
Erik W. Bush et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
Toward MicroRNA-Based Therapeutics for Heart Disease The Sense in Antisense
Eva van Rooij et al.
CIRCULATION RESEARCH (2008)
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
Thomas Thum et al.
NATURE (2008)
The regulatory activity of microRNA☆ species has substantial influence on microRNA and 3′ UTR evolution
Katsutomo Okamura et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
Emerging role of MicroRNAs in cardiovascular biology
Michael V. G. Latronico et al.
CIRCULATION RESEARCH (2007)
MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets
Eva Van Rooij et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
MicroRNAs in the human heart - A clue to fetal gene reprogramming in heart failure
Thomas Thum et al.
CIRCULATION (2007)
MicroRNA expression signature and antisense-mediated depletion reveal an essential role of microRNA in vascular neointimal lesion formation
Ruirui Ji et al.
CIRCULATION RESEARCH (2007)
MicroRNAs are aberrantly expressed in hypertrophic heart - Do they play a role in cardiac hypertrophy?
Yunhui Cheng et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy
Mariko Tatsuguchi et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2007)
MicroRNA-133 controls cardiac hypertrophy
Alessandra Care et al.
NATURE MEDICINE (2007)
Control of stress-dependent cardiac growth and gene expression by a microRNA
Eva van Rooij et al.
SCIENCE (2007)
Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3β activity
Chinmay M. Trivedi et al.
NATURE MEDICINE (2007)
A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure
Eva van Rooij et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy
Yongli Kong et al.
CIRCULATION (2006)
Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding
HJ Kee et al.
CIRCULATION (2006)
Human RISC couples microRNA biogenesis and posttranscriptional gene silencing
RI Gregory et al.
CELL (2005)
Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy
E Takimoto et al.
NATURE MEDICINE (2005)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development
SR Chang et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Increased systolic performance with diastolic dysfunction in adult spontaneously hypertensive rats
OH Cingolani et al.
HYPERTENSION (2003)
Up-regulation of endothelial nitric-oxide synthase by endothelium-derived hyperpolarizing factor involves mitogen-activated protein kinase and protein kinase C signaling pathways
H Wang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Cardiac hypertrophy: The good, the bad and the ugly
N Frey et al.
ANNUAL REVIEW OF PHYSIOLOGY (2003)
Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy
CL Zhang et al.
CELL (2002)
Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart
T Matsui et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Akt/Protein kinase B promotes organ growth in transgenic mice
T Shioi et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo
CL Antos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
The human histone deacetylase family
SG Gray et al.
EXPERIMENTAL CELL RESEARCH (2001)
Share Paper
